75 results
8-K
EX-99.1
GYRE
Gyre Therapeutics Inc
14 Nov 23
Regulation FD Disclosure
12:00am
stock, etc.]
(5)[Major Shareholders]
(6)[Status of voting rights]
①[Issued Shares]
②[Treasury stock]
2 [Status of officers]
Fourth [Status … , or (iii) when a third party acquires shares equivalent to 50% of the voting rights of our shareholders, we notify the holders of the Share Acquisition
S-8
EX-4.7
9jl 5jp99pjnhm0xh1u8
30 Oct 23
Registration of securities for employees
5:46pm
8-K
EX-3.3
flhu5z 0hlrc
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
DEFM14A
s28spz
20 Jul 23
Proxy related to merger
8:57am
DEFA14A
EX-3.1
nz61xkmjnh7xpe
20 Jun 23
Additional proxy soliciting materials
5:02pm
DEFA14A
ywubnup9
20 Jun 23
Additional proxy soliciting materials
5:02pm
8-K
EX-3.1
lahgoz wiwnwd3apwaf
20 Jun 23
Material Modifications to Rights of Security Holders
5:00pm
8-K
u8n8uaev67zy3jij
20 Jun 23
Material Modifications to Rights of Security Holders
5:00pm
PRER14A
n0znmv
15 May 23
Preliminary revised proxy
4:02pm
PREM14A
7235jhwf3296t
30 Mar 23
Preliminary proxy related to merger
4:48pm
425
EX-3.1
x2lfod904m3 gca
27 Dec 22
Business combination disclosure
7:02am
425
s23187
27 Dec 22
Business combination disclosure
7:02am
8-K
vypz1kfq
27 Dec 22
Catalyst Biosciences Completes First Steps in Reverse Merger Plan
7:00am